Oncotherapy Science Of Japan To Start Cancer Drug Study In France
This article was originally published in PharmAsia News
Executive Summary
Japanese specialty drug maker Oncotherapy Science plans to start a clinical study for antibody oncology therapies in France next summer
Japanese specialty drug maker Oncotherapy Science plans to start a clinical study for antibody oncology therapies in France next summer. The company said its Lyon, France-based research partner obtained public funding from the local government to study the drug for synovial sarcoma. The two aim for an earlier commercialization and additional indications for other cancer types. (Click here for more - Japanese language) "Oncotherapy Science To Accelerate Antibody Development, Starts France Study Next Summer" - Nikkei Sangyo News (8/27/2010) |